Skip to main content
Lalan Wilfong, MD, Oncology, Dallas, TX

LalanScottWilfongMD

Oncology Dallas, TX

Physician

Dr. Wilfong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wilfong's full profile

Already have an account?

  • Office

    8220 Walnut Hill LN
    Suite 700 Professional Building II
    Dallas, TX 75231
    Phone+1 214-739-4175
    Fax+1 214-987-4161

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 2000
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1997

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2026
  • American Board of Internal Medicine Medical Oncology
  • National Board of Physicians and Surgeons Hematology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Lectures

  • Clinical and economic outcomes of pegfilgrastim in metastatic colorectal cancer. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • Easier Said Than Done: Why Scaling up Value-Based Care Is so Hard (And What We Can Do About It)
    Easier Said Than Done: Why Scaling up Value-Based Care Is so Hard (And What We Can Do About It)December 15th, 2024
  • What Will It Mean to Say ‘I Have Cancer’ in Dallas-Fort Worth 10 Years from Now
    What Will It Mean to Say ‘I Have Cancer’ in Dallas-Fort Worth 10 Years from NowOctober 29th, 2022
  • Can Biosimilars, After Years of Limited Impact, Finally Make a Mark in the US?
    Can Biosimilars, After Years of Limited Impact, Finally Make a Mark in the US?September 7th, 2022
  • Join now to see all